Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031180012Completed
Open-label trial of midazolam (2 arms), sponsored by Ministry of Education, Culture, Sports, Science and Technology. Primary endpoint: Pharmacokinetic parameters of serum midazolam. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031180012.